| abstract |
THE INVENTION CONCERNS PHENYL-1,2,4-OXADIAZOLONE DERIVATIVES IN ALL THEIR STEREOISOMERIC FORMS AND THEIR MIXTURES IN ANY KIND, AS WELL AS THE PHYSIOLOGICALLY ACCEPTABLE SALTS AND THE TAUTOMERIC FORMS OF TWO THOSE THAT EXERCISE AN AGONIST ACTIVITY ON THE PPAR? RECEIVERS. The invention thus describes compounds represented by the formula (I), in which the radicals are as defined in the description, as well as the physiologically acceptable salts thereof and the processes used to obtain them. THESE COMPOUNDS ARE USED TO TREAT AND / OR PREVENT FATTY ACID METABOLISM DISORDERS, GLUCOSE USE DISORDERS, DISORDERS INVOLVING INSULIN RESISTANCE AND DEMYLINATION, AND OTHER NEURODEGENERATIVE DISORDERS OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM . |